| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.21 | 3e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |